US Stock MarketDetailed Quotes

TRXDW ASENSUS SURGICAL INC C/WTS 10/03/2025 (TO PUR COM)SER D

Watchlist
  • 0.001
  • 0.0000.00%
15min DelayTrading Jul 24 16:00 ET
0Market Cap0.00P/E (TTM)

About ASENSUS SURGICAL INC C/WTS 10/03/2025 (TO PUR COM)SER D Company

TransEnterix, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, economic shortcomings in surgery. The Senhance Surgical System features as the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.

Company Profile

SymbolTRXDW
Company NameASENSUS SURGICAL INC C/WTS 10/03/2025 (TO PUR COM)SER D
Listing DateApr 15, 2014
Founded2006
CEOMr. Anthony C. J. Fernando
MarketPink Market
Employees209
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address635 Davis Drive,Suite 300
CityMorrisville
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27560
Phone1-919-765-8400

Company Executives

  • Name
  • Position
  • Salary
  • Anthony C. J. Fernando
  • President, Chief Executive Officer and Director
  • 2.11M
  • Shameze Rampertab
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 1.03M
  • David B. Milne
  • Chairman of the Board
  • 151.98K
  • Richard C. Pfenniger, Jr
  • Independent Director
  • 101.20K
  • Andrea Biffi
  • Independent Director
  • 52.73K
  • Dr. Elizabeth Kwo, M.D.
  • Independent Director
  • 81.20K
  • William N. Starling
  • Independent Director
  • 90.98K
  • Kevin J. Hobert
  • Independent Director
  • 83.98K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg